Literature DB >> 23836224

How cytokine networks fuel inflammation: Toward a cytokine-based disease taxonomy.

Georg Schett1, Dirk Elewaut, Iain B McInnes, Jean-Michel Dayer, Markus F Neurath.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23836224     DOI： 10.1038/nm.3260

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  15 in total

Review 1.  The role of Th1/Th2 polarization in mucosal immunity.

Authors:  Markus F Neurath; Susetta Finotto; Laurie H Glimcher
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

2.  Autoimmunity's next top models.

Authors:  Hartmut Wekerle; Alexander Flügel; Lars Fugger; Georg Schett; David Serreze
Journal:  Nat Med       Date:  2012-01-06       Impact factor: 53.440

3.  Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial.

Authors:  Wolfgang Hueber; Bruce E Sands; Steve Lewitzky; Marc Vandemeulebroecke; Walter Reinisch; Peter D R Higgins; Jan Wehkamp; Brian G Feagan; Michael D Yao; Marek Karczewski; Jacek Karczewski; Nicole Pezous; Stephan Bek; Gerard Bruin; Bjoern Mellgard; Claudia Berger; Marco Londei; Arthur P Bertolino; Gervais Tougas; Simon P L Travis
Journal:  Gut       Date:  2012-05-17       Impact factor: 23.059

4.  Cracking the cytokine code in psoriasis.

Authors:  Brian J Nickoloff
Journal:  Nat Med       Date:  2007-03       Impact factor: 53.440

Review 5.  Clinical practice. Gout.

Authors:  Tuhina Neogi
Journal:  N Engl J Med       Date:  2011-02-03       Impact factor: 91.245

Review 6.  TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease.

Authors:  L Probert; H P Eugster; K Akassoglou; J Bauer; K Frei; H Lassmann; A Fontana
Journal:  Brain       Date:  2000-10       Impact factor: 13.501

Review 7.  Janus kinase inhibitors in autoimmune diseases.

Authors:  John J O'Shea; Apostolos Kontzias; Kunihiro Yamaoka; Yoshiya Tanaka; Arian Laurence
Journal:  Ann Rheum Dis       Date:  2013-04       Impact factor: 19.103

8.  Ustekinumab induction and maintenance therapy in refractory Crohn's disease.

Authors:  William J Sandborn; Christopher Gasink; Long-Long Gao; Marion A Blank; Jewel Johanns; Cynthia Guzzo; Bruce E Sands; Stephen B Hanauer; Stephan Targan; Paul Rutgeerts; Subrata Ghosh; Willem J S de Villiers; Remo Panaccione; Gordon Greenberg; Stefan Schreiber; Simon Lichtiger; Brian G Feagan
Journal:  N Engl J Med       Date:  2012-10-18       Impact factor: 91.245

Review 9.  Keynote review: phosphodiesterase-4 as a therapeutic target.

Authors:  Miles D Houslay; Peter Schafer; Kam Y J Zhang
Journal:  Drug Discov Today       Date:  2005-11-15       Impact factor: 7.851

10.  Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.

Authors:  C A Dinarello; J G Cannon; S M Wolff; H A Bernheim; B Beutler; A Cerami; I S Figari; M A Palladino; J V O'Connor
Journal:  J Exp Med       Date:  1986-06-01       Impact factor: 14.307
View more
  130 in total

Review 1.  [Biosimilars in rheumatology. Development and results of clinical trials].

Authors:  R Alten
Journal:  Z Rheumatol       Date:  2015-10       Impact factor: 1.372

Review 2.  White Adipose Tissue Browning: A Double-edged Sword.

Authors:  Abdikarim Abdullahi; Marc G Jeschke
Journal:  Trends Endocrinol Metab       Date:  2016-07-05       Impact factor: 12.015

3.  Preventive activity of banana peel polyphenols on CCl4-induced experimental hepatic injury in Kunming mice.

Authors:  Rui Wang; Xia Feng; Kai Zhu; Xin Zhao; Huayi Suo
Journal:  Exp Ther Med       Date:  2016-03-11       Impact factor: 2.447

Review 4.  Regulation of tumour necrosis factor signalling: live or let die.

Authors:  Dirk Brenner; Heiko Blaser; Tak W Mak
Journal:  Nat Rev Immunol       Date:  2015-06       Impact factor: 53.106

Review 5.  IL-23 responsive innate-like T cells in spondyloarthritis: the less frequent they are, the more vital they appear.

Authors:  Koen Venken; Dirk Elewaut
Journal:  Curr Rheumatol Rep       Date:  2015-05       Impact factor: 4.592

6.  Delayed revascularization of islets after transplantation by IL-6 blockade in pig to non-human primate islet xenotransplantation model.

Authors:  Byoung-Hoon Min; Jun-Seop Shin; Jong-Min Kim; Seong-Jun Kang; Hyun-Je Kim; Il-Hee Yoon; Su-Kyoung Park; Ji-Won Choi; Min-Suk Lee; Chung-Gyu Park
Journal:  Xenotransplantation       Date:  2017-12-06       Impact factor: 3.907

Review 7.  Aligning mouse models of asthma to human endotypes of disease.

Authors:  Rebecca A Martin; Samantha R Hodgkins; Anne E Dixon; Matthew E Poynter
Journal:  Respirology       Date:  2014-05-09       Impact factor: 6.424

Review 8.  Inflammatory osteolysis: a conspiracy against bone.

Authors:  Gabriel Mbalaviele; Deborah V Novack; Georg Schett; Steven L Teitelbaum
Journal:  J Clin Invest       Date:  2017-06-01       Impact factor: 14.808

9.  Ocular cytomegalovirus latency exacerbates the development of choroidal neovascularization.

Authors:  Jinxian Xu; Xinglou Liu; Xinyan Zhang; Brendan Marshall; Zheng Dong; Yutao Liu; Diego G Espinosa-Heidmann; Ming Zhang
Journal:  J Pathol       Date:  2020-05-21       Impact factor: 7.996

Review 10.  Cytokines in rheumatoid arthritis - shaping the immunological landscape.

Authors:  Iain B McInnes; Christopher D Buckley; John D Isaacs
Journal:  Nat Rev Rheumatol       Date:  2015-12-10       Impact factor: 20.543
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.